Probiotics are non-pathogenic bacteria that, when consumed, have a beneficial effect on the host's health or physiology. They can have a direct or indirect impact on intestinal physiology by modulating the endogenous environment or immune system. They are made up of yeast or bacteria, particularly lactic acid bacteria. Probiotic microorganisms have been discovered to be useful in the treatment of gastrointestinal problems. From the mouth to the anus, Gastrointestinal (GI) illnesses affect the GI tract. The gastrointestinal microflora has also been suggested to be involved in the pathogenesis of inflammatory bowel diseases in genetically predisposed subjects with immunological dysregulation. Enterotoxinogenic E. coli, salmonellae and shigellae account for about 80% of cases with an identified pathogen in acute diarrhoea. Irritable bowel disease is made up of two primary components: Crohn's disease and ulcerative colitis. The mucosal immune system's initial line of defence is a polarised single layer of epithelial cells covered by a mucus biofilm generated by goblet cells with bacteria intermingled. Microbicidal action is seen in all forms of defensins, and some also have activity against fungi and viruses. Understanding the virulence pathways that are common among important pathogens could lead to novel techniques for making bacteria more sensitive to the immune system's antibacterial arsenal.
Share this article